placeholder newsslider

News in Detail

Glaukos Expands its Preserflo MicroShunt Relationship With Santen via New License Agreement

Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties.